1. Home
  2. ELVN vs MRC Comparison

ELVN vs MRC Comparison

Compare ELVN & MRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ELVN
  • MRC
  • Stock Information
  • Founded
  • ELVN 2016
  • MRC 1921
  • Country
  • ELVN United States
  • MRC United States
  • Employees
  • ELVN N/A
  • MRC N/A
  • Industry
  • ELVN Biotechnology: Pharmaceutical Preparations
  • MRC Industrial Machinery/Components
  • Sector
  • ELVN Health Care
  • MRC Industrials
  • Exchange
  • ELVN Nasdaq
  • MRC Nasdaq
  • Market Cap
  • ELVN 1.1B
  • MRC 1.2B
  • IPO Year
  • ELVN 2020
  • MRC 2012
  • Fundamental
  • Price
  • ELVN $20.46
  • MRC $13.76
  • Analyst Decision
  • ELVN Strong Buy
  • MRC Strong Buy
  • Analyst Count
  • ELVN 5
  • MRC 3
  • Target Price
  • ELVN $37.80
  • MRC $16.33
  • AVG Volume (30 Days)
  • ELVN 215.9K
  • MRC 495.0K
  • Earning Date
  • ELVN 03-13-2025
  • MRC 02-11-2025
  • Dividend Yield
  • ELVN N/A
  • MRC N/A
  • EPS Growth
  • ELVN N/A
  • MRC N/A
  • EPS
  • ELVN N/A
  • MRC 0.67
  • Revenue
  • ELVN N/A
  • MRC $3,203,000,000.00
  • Revenue This Year
  • ELVN N/A
  • MRC N/A
  • Revenue Next Year
  • ELVN N/A
  • MRC $1.13
  • P/E Ratio
  • ELVN N/A
  • MRC $20.43
  • Revenue Growth
  • ELVN N/A
  • MRC N/A
  • 52 Week Low
  • ELVN $10.90
  • MRC $9.77
  • 52 Week High
  • ELVN $30.03
  • MRC $14.91
  • Technical
  • Relative Strength Index (RSI)
  • ELVN 34.55
  • MRC 61.33
  • Support Level
  • ELVN $21.55
  • MRC $12.82
  • Resistance Level
  • ELVN $25.37
  • MRC $13.22
  • Average True Range (ATR)
  • ELVN 1.61
  • MRC 0.33
  • MACD
  • ELVN -0.12
  • MRC 0.10
  • Stochastic Oscillator
  • ELVN 5.76
  • MRC 99.25

About ELVN Enliven Therapeutics Inc.

Enliven Therapeutics Inc is a clinical-stage precision oncology company focused on the discovery and development of potentially first-in-class precision oncology therapies. Enliven's programs are designed to address issues such as tolerability, combinability, resistance and disease escape through brain metastases. Its product candidates include ELVN-001 which is a potent, selective, small molecule kinase inhibitor designed to specifically target the BCR-ABL gene fusion, the oncogenic driver for patients with chronic myeloid leukemia, and the ELVN-002 which is central nervous system (CNS) penetrant and irreversible HER2 inhibitor with activity against wild type HER2 and various HER2 mutations.

About MRC MRC Global Inc.

MRC Global Inc distributes pipes, valves, fittings, and related products and services to the energy industry. Products are often used in the construction, maintenance, repair, and overhaul of equipment used in extreme operating conditions. In these conditions and other environments, MRC's valve products give the customer the ability to control the direction, velocity, and pressure of fluids and gases within transmission networks. In addition, other products can be used to regulate flow and on/off service. MRC's other products, which include pipe, steel fitting, and tubular goods, are used across all of the industries in which the company operates. Specialized services are delivered alongside this array of products to enhance the client relationship.

Share on Social Networks: